First human tests begin for new Alzheimer's pill
NCT ID NCT06870058
Summary
This early-stage study tested the safety of an experimental oral drug called NH280105, which is being developed for Alzheimer's disease. Researchers gave the drug to 32 healthy adult volunteers to check for side effects and see how the body absorbs and processes it. The study also examined whether taking the drug with food affects how it works in the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CMAX Clinical Research Pty Ltd
Adelaide, South Australia, 5000, Australia
Conditions
Explore the condition pages connected to this study.